Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0GA3M
|
|||
| Former ID |
DIB004000
|
|||
| Drug Name |
BE-16627B
|
|||
| Synonyms |
BE-16627B; 137530-61-1; be16627b; AC1L30CH; L-N-(N-Hydroxy-2-isobutylsuccinamoyl)seryl-L-valine; L-Valine, N-(N-(2-(2-(hydroxyamino)-2-oxoethyl)-4-methyl-1-oxopentyl)-L-seryl)-; (2S)-2-[[(2S)-3-hydroxy-2-[[2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl]amino]propanoyl]amino]-3-methylbutanoic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Terminated | [1] | |
| Company |
MSD Japan
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H29N3O7
|
|||
| Canonical SMILES |
CC(C)CC(CC(=O)NO)C(=O)NC(CO)C(=O)NC(C(C)C)C(=O)O
|
|||
| InChI |
1S/C16H29N3O7/c1-8(2)5-10(6-12(21)19-26)14(22)17-11(7-20)15(23)18-13(9(3)4)16(24)25/h8-11,13,20,26H,5-7H2,1-4H3,(H,17,22)(H,18,23)(H,19,21)(H,24,25)/t10?,11-,13-/m0/s1
|
|||
| InChIKey |
ZTDAMCPLHAKWAY-KUNJKIHDSA-N
|
|||
| CAS Number |
CAS 137530-61-1
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Matrix metalloproteinase (MMP) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006074) | |||
| REF 2 | Gelatinase B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma. Int J Cancer. 1999 Aug 27;82(5):743-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.